Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
115
datasets available to search
ShareScore release 0.9.0
Dataset results
115 results for “upadacitinib”
A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting
ClinicalTrials.gov study NCT07073079. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)
ClinicalTrials.gov study NCT05989932. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.
ClinicalTrials.gov study NCT07354906. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therapy in Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT07008846. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid Arthritis
ClinicalTrials.gov study NCT04267536. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's Disease
ClinicalTrials.gov study NCT06446219. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants
ClinicalTrials.gov study NCT05609630. IPD Sharing: YES. Countries: 17. Publications: 0.
A Study of the Change in Early and Sustained Pain Control in Axial Spondylarthritis in Adult Participants Receiving Upadacitinib
ClinicalTrials.gov study NCT04846244. IPD Sharing: UNDECIDED. Countries: 16. Publications: 0.
IUS Predicts Upadacitinib Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study
ClinicalTrials.gov study NCT06573944. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease
ClinicalTrials.gov study NCT06459297. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
ClinicalTrials.gov study NCT05782907. IPD Sharing: YES. Countries: 23. Publications: 0.
An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World
ClinicalTrials.gov study NCT05669794. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
ClinicalTrials.gov study NCT06118411. IPD Sharing: YES. Countries: 19. Publications: 0.
Efficacy and Safety Analysis of Upadacitinib in Inflammatory Bowel Disease
ClinicalTrials.gov study NCT06274996. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Ther
ClinicalTrials.gov study NCT05889182. IPD Sharing: YES. Countries: 37. Publications: 0.
An Observational Study to Assess the Impact of Upadacitinib in Adult Hungarian Participants With Moderate to Severe Rheumatoid Arthritis (RA) in Real-World Practice
ClinicalTrials.gov study NCT05327920. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis
ClinicalTrials.gov study NCT07018206. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)
ClinicalTrials.gov study NCT04161898. IPD Sharing: YES. Countries: 6. Publications: 0.
Upadacitinib for Refractory Behcet's Syndrome
ClinicalTrials.gov study NCT07080346. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting
ClinicalTrials.gov study NCT05094128. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.